Immunoblotting showed that MKRN1 knockdown and overexpression had opposite effects on TGF-β, inhibiting and activating the pathway, respectively (Fig. 6E, F), suggesting that high MKRN1 levels may facilitate CRC progression through TGF-β signalling. The gene discussed is MKRN1; the disease is colorectal carcinoma.